123 related articles for article (PubMed ID: 26296926)
1. High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor.
Terry-Lorenzo RT; Masuda K; Sugao K; Fang QK; Orsini MA; Sacchi S; Pollegioni L
J Biomol Screen; 2015 Dec; 20(10):1218-31. PubMed ID: 26296926
[TBL] [Abstract][Full Text] [Related]
2. Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction.
Birolo L; Sacchi S; Smaldone G; Molla G; Leo G; Caldinelli L; Pirone L; Eliometri P; Di Gaetano S; Orefice I; Pedone E; Pucci P; Pollegioni L
FEBS J; 2016 Sep; 283(18):3353-70. PubMed ID: 27400736
[TBL] [Abstract][Full Text] [Related]
3. The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain.
Cappelletti P; Campomenosi P; Pollegioni L; Sacchi S
FEBS J; 2014 Feb; 281(3):708-23. PubMed ID: 24237903
[TBL] [Abstract][Full Text] [Related]
4. pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.
Sacchi S; Bernasconi M; Martineau M; Mothet JP; Ruzzene M; Pilone MS; Pollegioni L; Molla G
J Biol Chem; 2008 Aug; 283(32):22244-56. PubMed ID: 18544534
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the interaction of D-amino acid oxidase with pLG72 in a glial cell line.
Sacchi S; Cappelletti P; Giovannardi S; Pollegioni L
Mol Cell Neurosci; 2011 Sep; 48(1):20-8. PubMed ID: 21679769
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility.
Sacchi S; Cappelletti P; Pirone L; Smaldone G; Pedone E; Pollegioni L
FEBS Lett; 2017 Feb; 591(4):646-655. PubMed ID: 28166363
[TBL] [Abstract][Full Text] [Related]
7. D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation.
Pollegioni L; Piubelli L; Molla G; Rosini E
Front Mol Biosci; 2018; 5():3. PubMed ID: 29417050
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
Caldinelli L; Sacchi S; Molla G; Nardini M; Pollegioni L
Biochim Biophys Acta; 2013 Mar; 1832(3):400-10. PubMed ID: 23219954
[TBL] [Abstract][Full Text] [Related]
9. Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment.
Caldinelli L; Molla G; Bracci L; Lelli B; Pileri S; Cappelletti P; Sacchi S; Pollegioni L
Protein Sci; 2010 Aug; 19(8):1500-12. PubMed ID: 20521334
[TBL] [Abstract][Full Text] [Related]
10. Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation.
Terry-Lorenzo RT; Chun LE; Brown SP; Heffernan ML; Fang QK; Orsini MA; Pollegioni L; Hardy LW; Spear KL; Large TH
Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 25001371
[TBL] [Abstract][Full Text] [Related]
11. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs.
Cappelletti P; Piubelli L; Murtas G; Caldinelli L; Valentino M; Molla G; Pollegioni L; Sacchi S
Biochim Biophys Acta; 2015 Sep; 1854(9):1150-9. PubMed ID: 25701391
[TBL] [Abstract][Full Text] [Related]
13. G72 primate-specific gene: a still enigmatic element in psychiatric disorders.
Sacchi S; Binelli G; Pollegioni L
Cell Mol Life Sci; 2016 May; 73(10):2029-39. PubMed ID: 26914235
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Properties and Physiological Functions of pLG72: Twenty Years of Investigations.
Murtas G; Pollegioni L; Molla G; Sacchi S
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740983
[TBL] [Abstract][Full Text] [Related]
15. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
16. Expression in Escherichia coli and in vitro refolding of the human protein pLG72.
Molla G; Bernasconi M; Sacchi S; Pilone MS; Pollegioni L
Protein Expr Purif; 2006 Mar; 46(1):150-5. PubMed ID: 16183301
[TBL] [Abstract][Full Text] [Related]
17. Relevance of weak flavin binding in human D-amino acid oxidase.
Caldinelli L; Molla G; Sacchi S; Pilone MS; Pollegioni L
Protein Sci; 2009 Apr; 18(4):801-10. PubMed ID: 19309736
[TBL] [Abstract][Full Text] [Related]
18. Optimization of human D-amino acid oxidase expression in Escherichia coli.
Romano D; Molla G; Pollegioni L; Marinelli F
Protein Expr Purif; 2009 Nov; 68(1):72-8. PubMed ID: 19497370
[TBL] [Abstract][Full Text] [Related]
19. pLG72 induces superoxide radicals via interaction and aggregation with SOD1.
Wang M; Saw HP; Cui FF; Lin SY; Chang HT; Chiu CD
Free Radic Res; 2018 Sep; 52(9):970-976. PubMed ID: 30037290
[TBL] [Abstract][Full Text] [Related]
20. Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors.
Bernetti M; Rosini E; Mollica L; Masetti M; Pollegioni L; Recanatini M; Cavalli A
J Chem Inf Model; 2018 Nov; 58(11):2255-2265. PubMed ID: 30339750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
